ID | 366 |
No | 366 |
Brand Name | OMEPAZ |
Ingredients | OMEPRAZOLE SODIUM EQ. TO OMEPRAZOLE 40 MG |
Dosage Form | POWDER FOR SOLUTION FOR INJECTION |
Primary Packaging | VIAL |
Storage | STORE IN A COOL, DRY PLACE, TEMPERATURE BELOWE 25'C, PROTECTED FROM LIGHT. |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 1 VIAL AND 1 AMPOULE WITH 10 ML WATER FOR INJECTION |
Dispensing Category | Prescription only |
ATC Classification | A02BC01 |
Pharmaceutical Class | antiulcer |
Indications | TREATMENT OF DUODENAL ULCERS, PREVENTION OF RELAPSE OF DUODENAL ULCERS, TREATMENT AND PREVENTION OF RELAPSE OF GASTRIC ULCERS, TREATMENT AND PREVENTION OF NSAID-ASSOCIATED GASTRIC AND DUODENAL ULCERS IN PATIENTS AT RISK, TREATMENT OF REFLUX OESOPHAGITIS, TREATMENT OF ZOLLINGER-ELLISON SYNDROME. |
Contraindications | HYPERSENSITIVITY TO OMEPRAZOLE SUBSTITUTED BENZIMIDAZOLES OR TO ANY OF THE EXCIPIENTS |
Side Effects | THE MOST COMMON SIDE EFFECTS (1-10% OF PATIENTS) ARE HEADACHE, ABDOMINAL PAIN,CONSTIPATION, DIARRHEA, FLATULENCE AND NAUSEA/VOMITING. |
Unit Price | - |
EDL |
Yes |
Description | WHITE OR ALMOST WHITE LOOSE POWDER |
Note | |
License Owner | CBF PHARMA CO.,LTD |
Manufacturer | CISEN PHARMACEUTICAL CO.,LTD |
Country | CHINA |
Import Registration No | GYZZ H20083922 |
Import Registration Date | 2018-04-04 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-03-21 |
FDD Registration No | 11 I 3926/13 |
FDD Registration Date | 2023-08-14 |
Expiry Date | 2026-08-13 |